Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage

World Journal of Surgery

Volumn 26, Issue 4, 2002, Pages 451-456

  Shimahara, Yasuyuki ^a   Yamamoto, Naritaka ^a   Uyama, Naoki ^a   Okuyama, Hiroaki ^a   Momoi, Hirohito ^a   Kamikawa, Tatsuhiko ^a   Terajima, Hiroaki ^a   Iimuro, Yuji ^a   Yamamoto, Yuzo ^a   Ikai, Iwao ^a   Kushihata, Fumiki ^b   Kiyochi, Hidenori ^b   Kobayashi, Nobuaki ^b   Yamaoka, Yoshio ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; COLLAGEN TYPE 4; INDOCYANINE GREEN; COLORING AGENT; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME ACTIVITY; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; SURGICAL RISK; BLOOD; CHRONIC DISEASE; LIVER FUNCTION TEST; MIDDLE AGED; POSTOPERATIVE PERIOD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHOLINESTERASES; CHRONIC DISEASE; COLLAGEN TYPE IV; COLORING AGENTS; FEMALE; HEPATECTOMY; HUMANS; INDOCYANINE GREEN; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD;

EID: 0036546678     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-001-0248-4     Document Type: Article

References (15)

1. Hernandez AM, Amenta PS. The hepatic extracellular matrix: components and distribution in normal liver. Virchows Arch. A. Pathol. Anat. 1993;423:1-11
2. Trinchet JC, Hartmann DJ, Pateron D, et al. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis: relationship to liver histology and conventional liver test. Hepatol. 1991;12:139-144
3. Niemelae O, Risteli L, Sotaniemi EA, et al. Type IV collagen and laminin-related antigens in human serum alcoholic liver disease. Eur. J. Clin. Invest. 1985;15:132-137
4. Sotaniemi EA, Niemelae O, Risteli L, et al. Fibrotic process and drug metabolism in alcoholic liver disease. Clin. Pharmacol. Ther. 1986;40:46-55
5. Tanikawa K. Serum marker for hepatic fibrosis and related liver pathology. Pathol. Res. Pract. 1994;190:960-968
6. Yamada S, Suou T, Kawasaki H, et al. Clinical significance of serum 7S collagen in various liver diseases. Clin. Biochem. 1992;25:467-470
7. Hahn E, Wick G, Pencev D, et al. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut 1980;21:63-71
8. Hernandez AM, Amenta PS. The extracellular matrix in hepatic regeneration. FASEB J. 1995;9:1401-1410
9. Obata K, Iwata K, Ichida T, et al. One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies. Clin. Chim. Acta. 1989;181:293-303
10. Matsumoto E, Murawaki Y, Ooshima A. Increased amount of serum type IV collagen peptide in human liver fibrosis as determined by enzyme-immunoassay with monoclonal antibodies. Acta Pathol. Jpn. 1989;39:217-223
11. Murawaki Y, Ikuta Y, Koda M, et al. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver diseases: relationship to liver histology. Hepatology 1994;20:780-787
12. Friedman S, Bissel M. Hepatic fibrosis: new insights into pathogenesis. Hosp. Pract. 1990;15:43-50
13. Rojkind M, Kershenobich D. The extracellular matrix, fibrosis and cirrhosis. Amsterdam, Elsevier Science, In the Liver Annual, vol. 6, Arias, IM, Wilson, JHP, Frenkel, M, editors, 1987:302-333
14. Milani S, Herbst H, Schuppan D, et al. In situ hybridization for procollagen type I, III, and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology 1989;10:84-92
15. Fabris C, Pirisi M, Falleti E, et al. Prediction of serum markers of fibrosis by levels of circulating intercellular adhesion molecule-1 in acute and chronic liver disease. Clin. Biochem. 1994;27:407-412